The sacroiliac joint fusion market is estimated to be valued at US$ 625.3 Mn in 2023 and is expected to exhibit a CAGR of 13.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Key Market Takeaways
:The sacroiliac joint fusion market is anticipated to witness a CAGR of 13.6% during the forecast period 2023-2030, owing to the growing geriatric population and increasing incidence of degenerative spine conditions.
- On the basis of product type, the minimally invasive SI joint fusion devices segment is expected to hold a dominant position, owing to advantages such as less invasive surgery and faster recovery times.
- On the basis of indication, degenerative sacroiliitis is expected to hold a dominant position over the forecast period, due to high prevalence among elderly patients.
- On the basis of end user, hospitals are expected to hold a dominant position, due to availability of advanced surgical facilities and trained medical professionals.
- Based on region, North America leads the sacroiliac joint fusion market, primarily due to the presence of key industry players and favorable reimbursement policies.
Sacroiliac Joint Fusion Market Report Coverage
|
Report Coverage
|
Details
|
|
Market Revenue in 2023
|
USD 625.3 Million
|
|
Estimated Value by 2030
|
USD 1,525.1 Million
|
|
Growth Rate
|
Poised to grow at a CAGR of 13.6%
|
|
Historical Data
|
2018–2022
|
|
Forecast Period
|
2023–2030
|
|
Forecast Units
|
Value (USD Million/Billion)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Segments Covered
|
By Product Type, By Indication, By End User
|
|
Geographies Covered
|
North America, Europe, Asia Pacific, and Rest of World
|
|
Growth Drivers
|
• Increasing Prevalence of Sacroiliac Joint Disorders
• Strong Efficacy of Minimally Invasive SI Joint Fusion Procedures
|
|
Restraints & Challenges
|
• High Costs and Unfavorable Reimbursement Policies
• Availability of Traditional Conservative Therapies |
Market Dynamics
:The sacroiliac joint fusion market is expected to grow exponentially owing to the rising incidence of low back pain across the globe. According to the National Institute of Health, approximately 80% of the global population experience low back pain at some point in their lives.
The other major driver for the sacroiliac joint fusion market growth is the availability of minimally invasive procedures for sacroiliac joint fusion. Minimally invasive techniques involve smaller incisions and cuts and allow for a faster recovery time with less post-operative pain.
Market Trends
:- There has been a significant rise in the adoption of robot-assisted sacroiliac joint fusion procedures globally. Robot-assisted surgeries provide certain advantages over traditional open surgeries such as reduced risk of infections, less blood loss, shorter hospital stays, and quicker recovery times.
- Major players in the sacroiliac joint fusion market are increasingly investing in research and development of biologic alternatives to sacroiliac joint fusion, which includes therapies such as platelet-rich plasma injections and stem cell therapies. These biologic therapies focus on regenerating tissues around the damaged sacroiliac joint rather than fusing it, providing a minimally invasive treatment option to patients.
Market Opportunities
:- The minimally invasive SI joint fusion devices segment is expected to hold the largest market share over the forecast period. Key players in the sacroiliac joint fusion market are focusing on developing new technologically advanced minimally invasive fusion systems and percutaneous implantation techniques to further drive the growth of this segment.
- As the geriatric population grows worldwide, the prevalence of degenerative spine conditions is increasing significantly. This will boost the demand for sacroiliac joint fusion procedures among patients suffering from degenerative sacroiliitis.
Competitor Insights
Key players in the sacroiliac joint fusion market include:
- SI-BONE
- Medtronic
- SIGNUS Medizintechnik GmbH
- Xtant Medical
- Life Spine
- Globus Medical
- CoreLink
- Orthofix
- Zyga Technology
- Alphatec Spine
- Integra LifeSciences
- DePuy Synthes
- NuVasive
- RTI Surgical
Recent Developments
:- On October 31, 2023, Xēnix Medical, a surgical implant company, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the SOLACE™ Sacroiliac Fixation System. This system features the proprietary NANOACTIV™ surface technology and is compatible with Medtronic's StealthStation® Navigation system.
- In March 2022, Life Spine, a medical technology manufacturer, received additional 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its SImpact® SI Joint Fixation System, specifically for Posterior-Oblique approaches.
Market Segmentation:
By Product Type
-
- Minimally Invasive SI Joint Fusion Devices
- Open Surgery SI Joint Fusion Devices
- Arthrodesis Devices
- Allografts
- Screws
- Plates
- Others (Nails, Rods, etc.)
By Indication
-
- Degenerative Sacroiliitis
- Sacral Disruption
- Others (Failed Back Surgery, Trauma, Infection, etc.)
By End Users
-
- Hospitals
- ASCs
- Specialty Clinics
- Others (Research, Academic Institutes, etc.)
By Region:
-
North America
:- U.S.
- Canada
Latin America
:- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
:- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
:- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
:- GCC Countries
- Israel
- Rest of Middle East
Africa
:- South Africa
- North Africa
- Central Africa